- Home
- ZBIO vs SKYT Comparison
ZBIO vs SKYT Comparison
Compare ZBIO & SKYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBIO
- SKYT
- Stock Information
- Founded
- ZBIO 2019
- SKYT 1991
- Country
- ZBIO United States
- SKYT United States
- Employees
- ZBIO N/A
- SKYT N/A
- Industry
- ZBIO
- SKYT Semiconductors
- Sector
- ZBIO
- SKYT Technology
- Exchange
- ZBIO NYSE
- SKYT Nasdaq
- Market Cap
- ZBIO 389.2M
- SKYT 427.5M
- IPO Year
- ZBIO 2024
- SKYT 2021
- Fundamental
- Price
- ZBIO $12.15
- SKYT $9.83
- Analyst Decision
- ZBIO Strong Buy
- SKYT Strong Buy
- Analyst Count
- ZBIO 7
- SKYT 2
- Target Price
- ZBIO $32.29
- SKYT $11.50
- AVG Volume (30 Days)
- ZBIO 189.4K
- SKYT 692.9K
- Earning Date
- ZBIO 08-16-2025
- SKYT 08-06-2025
- Dividend Yield
- ZBIO N/A
- SKYT N/A
- EPS Growth
- ZBIO N/A
- SKYT N/A
- EPS
- ZBIO N/A
- SKYT N/A
- Revenue
- ZBIO $15,000,000.00
- SKYT $323,929,000.00
- Revenue This Year
- ZBIO $165.20
- SKYT N/A
- Revenue Next Year
- ZBIO $63.75
- SKYT $22.00
- P/E Ratio
- ZBIO N/A
- SKYT N/A
- Revenue Growth
- ZBIO N/A
- SKYT 7.90
- 52 Week Low
- ZBIO $5.83
- SKYT $5.63
- 52 Week High
- ZBIO $26.25
- SKYT $19.00
- Technical
- Relative Strength Index (RSI)
- ZBIO N/A
- SKYT 55.43
- Support Level
- ZBIO N/A
- SKYT $9.62
- Resistance Level
- ZBIO N/A
- SKYT $11.06
- Average True Range (ATR)
- ZBIO 0.00
- SKYT 0.53
- MACD
- ZBIO 0.00
- SKYT -0.06
- Stochastic Oscillator
- ZBIO 0.00
- SKYT 46.25
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.
About SKYT SkyWater Technology Inc.
SkyWater Technology Inc is a U.S.-based, independent, pure-play technology foundry that offers semiconductor development and manufacturing services from its fabrication facilities. In its technology as a service model, it leverages a foundation of proprietary technology, engineering to co-develop process technology intellectual property (IP) with its customers that enable disruptive concepts through its Technology Services for diverse microelectronics (integrated circuits) and related micro- and nanotechnology applications. It focuses on serving diversified, high-growth, end users in numerous vertical markets, including computation, aerospace and defense (A&D), automotive and transportation, bio-health, and industrial.